One of Chicago’s most influential tech figures and the founder of Groupon, Eric Lefkofsky, has contributed millions of dollars in support of cancer research in the course of his career. Currently, Lefkofsky is the brain and financial muscle behind the company that intends to use a smarter approach in its quest to find a cure for cancer.
Tempus is a tech company dedicated to battling and eradication of cancer. It helps doctors across the United States to give personalized medical care to cancer patients through its machine learning and interactive platform. Tempus’ objective is to benefit each and every cancer patient from the treatment of the person that came before them by providing doctors and medical staff with available information and appropriate cancer treatment tools. Tempus empowers physicians to make data-driven decisions in real-time by delivering genomic sequencing services and a complete analysis of therapeutic and molecular data. At the moment, Tempus is only working with pancreatic, lung and breast cancer, but more types of cancer will soon be incorporated into the program.
Eric Lefkofsky’s Portfolio
Lefkofsky (www.lefkofsky.com/) is the CEO and co-founder of the health tech start-up Tempus. Tempus is Eric Lefkofsky’s latest venture. Prior to founding Tempus, Lefkosfsky has worked with companies such as InnerWorkings; a global provider of promotional solutions and managed print, Echo Global Logistics; a tech-enabled logistics and transportation outsourcing company, and Mediaocean; a top supplier of integrated media procuring technology. He is also the co-founder of one of the biggest predictive analytics platform for the world’s leading industries, Uptake. He serves as the chairman, co-founder and former CEO of the global e-commerce marketplace, Groupon. He is the managing director and co-founder of Lightbank Ventures, a company that focusses on investments on disruptive technology.
Eric Lefkofsky attended Michigan University and got his Juris Doctor at University of Michigan Law School. He is an author of Accelerated Disruption and an adjunct professor at the University of Chicago. He serves at Chicago’s Steppenwolf Theatre Company as the Chairman of the Board of Trustees. He is a trustee at World Business Chicago, The Museum of Science and Industry, The Art Institute of Chicago, and the Lurie Children’s Hospital of Chicago.
Together with his wife Liz, Lefkosfsky established a private charitable foundation in 2006 to enhance the lives of communities they serve. Through the Lefkofsky Family Foundation, Lefkofsky and his wife Liz frequently give to cancer research causes in different parts of the United States. The helped fund the New York’s Weill Cornell Medicine for breast cancer research by donating $250,000. They also gave $1.2 million towards cancer research at the University of Michigan. Lefkofsky Family Foundation gave $500,000 to Stanford University’s immunotherapy for gastric cancer research team and $1 million to Northwestern University’s Robert H. Lurie Comprehensive Cancer Centre.